Cancer News and Research

Latest Cancer News and Research

Novel compound in avocados may offer a route to better leukemia treatment

A compound in avocados may ultimately offer a route to better leukemia treatment, says a new University of Guelph study.

29 Apr 2021

Geisinger wins $3.6 million contract to study the role of genetic variation in cancer

The National Cancer Institute (NCI), part of the National Institutes of Health, has awarded a 5-year, $3.6 million contract to Geisinger to study the role of genetic variation in cancer.

29 Apr 2021

Primary care practitioners overestimate disease risks leading to over-diagnosis and overtreatment

Primary care practitioners often over-estimate the likelihood of a patient having a medical condition based on reported symptoms and laboratory test results.

29 Apr 2021

New book provides details on the roles of inflammation in head and neck malignancy

'Head and Neck Cancer: Hallmarks of The Inflammation Ecosystem' aims to highlight the significant roles of inflammation in head and neck malignancy.

29 Apr 2021

Simple device can reduce swelling after kidney transplantation

In a published study, a team from Lawson Health Research Institute has found that a simple device can reduce swelling after kidney transplantation.

29 Apr 2021

Large heart attack study shows increased survival rates in patients with cardiogenic shock

The results of a large, national heart attack study show that patients with a deadly complication known as cardiogenic shock survived at a significantly higher rate when treated with a protocol developed by cardiologists at Henry Ford Hospital in collaboration with four metro Detroit hospitals.

29 Apr 2021

Researchers address the importance of increasing efforts to limit indoor tanning among minors

There is substantial evidence that indoor tanning is associated with increased risk of skin cancer – the most common type of cancer nationwide according to the American Cancer Society. Public health officials and researchers have become increasingly concerned about the health risks posed by indoor tanning.

29 Apr 2021

City of Hope initiates Phase 2 clinical trial to investigate if mushroom tablets could slow prostate cancer

City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, is now recruiting patients for a Phase 2 clinical trial to investigate whether pills containing white button mushroom extract could regulate the immune system, affecting prostate-specific antigen (PSA) levels to either remain stable or decline.

29 Apr 2021

Researchers discover how SARS-CoV-2 hijacks human cell machinery to blunt immune response

Researchers at University of California San Diego School of Medicine have discovered one way in which SARS-CoV-2, the coronavirus that causes COVID-19, hijacks human cell machinery to blunt the immune response, allowing it to establish infection, replicate and cause disease.

29 Apr 2021

Pancreatic cancer cells de-differentiate to spawn highly aggressive tumors, study shows

A Ludwig Cancer Research study has identified a previously unrecognized mechanism by which cancer cells of a relatively benign subtype of pancreatic tumors methodically revert-or "de-differentiate"-to a progenitor, or immature, state of cellular development to spawn highly aggressive tumors that are capable of metastasis to the liver and lymph nodes.

29 Apr 2021

New exosome-based therapeutic strategy to potentially treat late-stage colorectal cancer

In a recent discovery by University of Minnesota Medical School, researchers uncovered a new way to potentially target and treat late-stage colorectal cancer - a disease that kills more than 50,000 people each year in the United States.

29 Apr 2021

Immunocompromised children and young adults may experience prolonged SARS-CoV-2 infection

Children and young adults with compromised immune systems, such as those undergoing cancer treatment, may experience a prolonged period of infection with SARS-CoV-2, the virus that causes COVID-19, and the extended duration of infection may increase the incidence of mutations.

29 Apr 2021

New collaboration to study early detection of developmental differences in children

The University of Washington's School of Medicine Brotman Baty Institute for Precision Medicine is collaborating with Illumina, Inc. and GeneDx, Inc., a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company, to study early detection of developmental differences in children.

29 Apr 2021

Male bladder cancer vulnerability could be exploited to design new therapeutic strategies

A protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer.

29 Apr 2021

Researchers receive $3.75 million to study the impact of fluid flow on CAR-T cell therapy for brain cancer

Glioblastoma multiforme is among the most lethal of cancers and the most stubborn in the face of treatment. Fewer than 20 percent of patients survive more than two years after diagnosis, according to the Central Brain Tumor Registry of the United States.

29 Apr 2021

New method could be used to develop more effective treatments for cancer, metabolic disorders

Researchers from the University of Copenhagen have developed a new method that makes it possible to control human hormones and metabolism.

28 Apr 2021

Recovered COVID-19 patients show signs of long-term immunity

A study conducted by researchers in the United States has found that most patients who recovered from coronavirus disease 2019 (COVID-19) showed signs of long-lasting immunity against the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

28 Apr 2021

Cancer News and Research

Latest Cancer News and Research

Novel compound in avocados may offer a route to better leukemia treatment

Geisinger wins $3.6 million contract to study the role of genetic variation in cancer

Primary care practitioners overestimate disease risks leading to over-diagnosis and overtreatment

New book provides details on the roles of inflammation in head and neck malignancy

Simple device can reduce swelling after kidney transplantation

Large heart attack study shows increased survival rates in patients with cardiogenic shock

Researchers address the importance of increasing efforts to limit indoor tanning among minors

City of Hope initiates Phase 2 clinical trial to investigate if mushroom tablets could slow prostate cancer

Researchers discover how SARS-CoV-2 hijacks human cell machinery to blunt immune response

Pancreatic cancer cells de-differentiate to spawn highly aggressive tumors, study shows

New exosome-based therapeutic strategy to potentially treat late-stage colorectal cancer

Immunocompromised children and young adults may experience prolonged SARS-CoV-2 infection

New collaboration to study early detection of developmental differences in children

Male bladder cancer vulnerability could be exploited to design new therapeutic strategies

Researchers receive $3.75 million to study the impact of fluid flow on CAR-T cell therapy for brain cancer

New method could be used to develop more effective treatments for cancer, metabolic disorders

Recovered COVID-19 patients show signs of long-term immunity

UH center seeks to investigate vaccine hesitancy in Houston's underserved communities

Researchers develop first 3D organoid models of the pancreas from human stem cells

Young people of color with a higher income more likely to participate in cancer clinical trials

Understanding the DNA Damage Response in Innate Immunity eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in